TTK Healthcare Limited (BOM:507747)

Market Cap	12.71B -26.1%
Revenue (ttm)	8.30B +4.7%
Net Income	600.67M -28.3%
EPS	42.51 -28.3%
Shares Out	14.13M
PE Ratio	21.16
Forward PE	n/a
Dividend	10.00 (1.09%)
Ex-Dividend Date	Jul 18, 2025

Volume	240
Open	886.00
Previous Close	889.50
Day's Range	872.20 - 1,000.00
52-Week Range	737.00 - 1,402.00
Beta	0.31
Analysts	n/a
Price Target	n/a
Earnings Date	May 30, 2026

About TTK Healthcare

TTK Healthcare Limited engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, and Others segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, antiparasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pet parents. The Consumer Products segment...

• Industry: Pharmaceutical Preparations
• Founded: 1928
• Employees: 1,339
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 507747

Financial Performance

In fiscal year 2025, TTK Healthcare's revenue was 8.01 billion, an increase of 6.47% compared to the previous year's 7.53 billion. Earnings were 816.57 million, an increase of 29.94%.